Skip to main content

Animations

MJFF Publications

3431 - 3440 of 8808 Results
Title
Year
  • Year
  • 2011
  • 2011
  • 2022
  • 2020
  • 2017
  • 2008
  • 2015
  • 2012
  • 2022
  • 2023
  • Summary Details
    OPEN
    Title: Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awr139
    Citation Count: 111
  • Summary Details
    OPEN
    Title: Incidental Lewy body disease: Electrophysiological findings suggesting pre-clinical Lewy body disorders
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clinph.2011.03.033
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2022.147781
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative cases
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.08.015
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27132
    Citation Count: 107
  • Summary Details
    OPEN
    Title: UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nature07181
    Citation Count: 685
  • Summary Details
    OPEN
    Title: Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci78421
    Citation Count: 194
  • Summary Details
    OPEN
    Title: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244
    Citation Count: 325
  • Summary Details
    RESTRICTED
    Title: Preprint Highlight: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA- dependent STING signaling
    Journal Name: Molecular Biology of the Cell
    Publisher: American Society for Cell Biology (ASCB)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1091/mbc.p22-02-1003
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Membrane remodeling properties of the Parkinson’s disease protein LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2309698120
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.